Harnessing Exhaled Breath for Lung Cancer Early Detection—Results From the ExPeL Study
Clinical and Translational Science · 2026-08 · 19 (8)
DOI: 10.1111/cts.70687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 29.07.2026. Verfasst von Danita Kasi Patel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Manchester Institute of Biotechnology (MIB), Department of Chemistry, University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Hydrogen Peroxide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Northern Care Alliance Foundation Trust, Exhalation Technology Ltd..
Abstract (Originalsprache)
Scalable, non‐invasive tools are critically needed to improve early lung cancer detection and optimize primary care referral pathways. We evaluated Inflammacheck, a point‐of‐care device utilizing exhaled breath condensate (EBC) H 2 O 2 and physiological parameters with machine learning for non‐invasive lung cancer detection in a real‐world screening population. Exhaled Hydrogen Peroxide for Early Lung Cancer Detection (ExPeL) study participants, from the UK Targeted Lung Health Check (TLHC) programme, included individuals with suspected lung cancer and low‐risk ever‐smoker controls. EBC was collected via Inflammacheck, measuring H 2 O 2 , end‐tidal CO 2 , humidity, temperature, and exhalation flow rate. Multivariate analyses (PCA, LDA and Mahalanobis distance) assessed intrinsic group separation. SMOTE‐balanced data trained supervised machine learning models (stacked and voting ensembles), which were then evaluated on held‐out test sets. In parallel, untargeted LC–MS metabolomics was performed to identify discriminatory molecular features. Analyzing 34 participants with valid EBC data, 83% of cancer cases were early‐stage (I–II), reflecting a screening population. Multivariate analysis clearly separated lung cancer and controls across PCA, LDA, and Mahalanobis mapping. The voting ensemble model achieved: Accuracy 85.7%, Sensitivity 80%, Specificity 100%, Precision (PPV) 100%, ROC–AUC 0.90 and MCC 0.73. Crucially, no false positives were identified. EBC variables revealed greater dispersion in cancer patients, reflecting physiological heterogeneity missed by univariate analysis. Untargeted metabolomics identified 2132 features, with four key metabolites yielding an AUC of 0.969 for cancer discrimination. Inflammacheck effectively distinguishes early‐stage lung cancer via a rapid, non‐invasive breath test, findings which are highly relevant for primary care and screening triage, where non‐specific symptoms and low prevalence pose challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Manchester Institute of Biotechnology (MIB), Department of Chemistry, University of Manchester, Manchester, UK.
- School of Medicine, Pharmacy and Biomedical Sciences, Faculty of Science and Health, University of Portsmouth, Portsmouth, UK.
- Research and Innovation Department, Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
- Division of Immunology, Immunity to Infection and Respiratory Medicine; School of Biological Sciences; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- Respiratory Department, Salford Care Organisation, Northern Care Alliance Foundation Trust, Salford, UK.
- Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
ORCID-Profile: Danita Kasi Patel, Leon D'Cruz, Anoop Chauhan, Nawar Diar Bakerly, Seamus Grundy, Drupad K Trivedi, Sean Knight
Förderung
- Wellcome Trust
- Northern Care Alliance Foundation Trust
- Exhalation Technology Ltd.
Zitieren
APA
Patel, D. K., D'Cruz, L., Ahmed, W., Chauhan, A., Bakerly, N. D., Grundy, S., Trivedi, D. K., & Knight, S. (2026). Harnessing Exhaled Breath for Lung Cancer Early Detection—Results From the ExPeL Study. Clinical and Translational Science, 19(8). https://doi.org/10.1111/cts.70687
Vancouver
Patel DK, D'Cruz L, Ahmed W, Chauhan A, Bakerly ND, Grundy S, et al. Harnessing Exhaled Breath for Lung Cancer Early Detection—Results From the ExPeL Study. Clinical and Translational Science. 2026;19(8). doi:10.1111/cts.70687
BibTeX
@article{Patel2026,
author = {Patel, Danita Kasi and D'Cruz, Leon and Ahmed, Waqar and Chauhan, Anoop and Bakerly, Nawar Diar and Grundy, Seamus and Trivedi, Drupad K and Knight, Sean},
title = {Harnessing Exhaled Breath for Lung Cancer Early Detection—Results From the ExPeL Study},
journal = {Clinical and Translational Science},
year = {2026},
volume = {19},
number = {8},
doi = {10.1111/cts.70687}
}
EUVIMED